Clinical Nutrition Market | Growth, Trends, and Forecast

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

There are certain factors propelling the clinical nutrition growth of the market that includes the increasing prevalence of metabolic disorders, high spending on healthcare, and the rise of middle class in the emerging economies.

Over the past decade, the prevalence of metabolic disorders has increased, in terms of raw data. The actual number of patients opting for the diagnosis of metabolic disorders has increased over the last decade, thereby resulting in an increase in the number of patients diagnosed. Thus, with the rising prevalence of metabolic diseases, there is a great opportunity for market players to tap the emerging markets and establish their presence.

It has also been observed that healthcare expenditure continues to grow faster than economic growth in most of the countries, maintaining a trend observed over the decades. Therefore, as healthcare spending increases among major countries of the world, because of its wide applicability, the market is expected to witness high growth. There are many funding opportunities for clinical nutrition from governments across the world, including private foundations and the international community. The major funding organizations are National institutes of Health, US Department of Agriculture, Robert Woods Johnson Foundation, and Nestle Foundation. These funding opportunities are found propelling the growth of the market studied.

Scope of the Report

Clinical malnutrition is a disease condition that can be treated only with clinical intervention, through the use of specialized nutrients that are considered as proper medications, rather than as supplements. Clinical nutrition products help to keep the patient healthy and aid to improve the metabolic system of the body by providing adequate supplements, such as minerals, vitamins, and other supplements. Additionally, the high birth rate and a higher number of premature births also demand advanced clinical nutrition.

By Route of Administration
		Oral and Enteral
		Parenteral

By Application
		Nutritional Support for Malnutrition
		Nutritional Support for Metabolic Disorders
		Nutritional Support for Gastrointestinal Diseases
		Nutritional Support for Cancer
		Nutritional Support in Neurological Diseases
		Nutritional Support in Other Diseases

By End User
		Pediatric
		Adult

Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral and Enteral is Expected to have the Fastest Growth in the Route of Administration Segment

The oral and enteral segment accounts for the largest share, as they are used the most, followed by parenteral route. This is mainly because of the additional cost of processing the product/nutrient involved in enteral/parenteral routes.

Therefore, like the other routes of administration, physicians also prefer mostly the oral route, as it involves lesser complexities and costs, compared to the other two routes of administration. In addition, in most of the disease conditions, like chronic conditions and not acute conditions, the oral route is being preferred, thereby driving the overall market.

To understand key trends, Download Sample Report

Asia-Pacific holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

Asia-Pacific has the highest growth, in comparison to the other regions, in the forecast period. The major factors attributing to the growth of the Asia Pacific clinical nutrition market include an increase in the prevalence of metabolic disorders, a rise in the geriatric population in the Asia Pacific Region and high spending on healthcare. The prevalence of diabetes in China is also growing rapidly which is a major factor for obesity. As per the International Diabetes Federation (IDF) data, there were over 114,394,800 cases of diabetes in China in 2017 and the rate of prevalence of diabetes in the adults is 10.9%. The actual number of patients undergoing diagnosis of metabolic disorders has increased over the decade, hence, there is an increase in the number of patients diagnosed in the Asia Pacific region.

To understand geography trends, Download Sample Report.

Competitive Landscape

The industry players are found focusing on expansion through various inorganic strategies, such as acquisition, merger, strategic collaboration, and others, to gain significant market share and strengthen their product portfolios. Thus, the growing awareness about clinical nutrition has boosted the demand for pediatric, as well as adult nutrition formulae.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Prevalence of Metabolic Disorders
  2. 4.2.2 High Spending on Healthcare
  3. 4.2.3 Growing Geriatric Population
3. 4.3 Market Restraints
  1. 4.3.1 Imprecise Perception about Clinical Nutrition
  2. 4.3.2 Reduction in Birth Rates
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Route of Administration
  1. 5.1.1 Oral and Enteral
  2. 5.1.2 Parenteral
2. 5.2 By Application
  1. 5.2.1 Nutritional Support for Malnutrition
  2. 5.2.2 Nutritional Support for Metabolic Disorders
  3. 5.2.3 Nutritional Support for Gastrointestinal Diseases
  4. 5.2.4 Nutritional Support for Cancer
  5. 5.2.5 Nutritional Support in Neurological Diseases
  6. 5.2.6 Nutritional Support in Other Diseases
3. 5.3 By End User
  1. 5.3.1 Pediatric
  2. 5.3.2 Adult
4. 5.4 Geography
  1. 5.4.1 North America
    1. 5.4.1.1 United States
    2. 5.4.1.2 Canada
    3. 5.4.1.3 Mexico
  2. 5.4.2 Europe
    1. 5.4.2.1 Germany
    2. 5.4.2.2 United Kingdom
    3. 5.4.2.3 France
    4. 5.4.2.4 Italy
    5. 5.4.2.5 Spain
    6. 5.4.2.6 Rest of Europe
  3. 5.4.3 Asia-Pacific
    1. 5.4.3.1 China
    2. 5.4.3.2 Japan
    3. 5.4.3.3 India
    4. 5.4.3.4 Australia
    5. 5.4.3.5 South Korea
    6. 5.4.3.6 Rest of Asia-Pacific
  4. 5.4.4 Middle East & Africa
    1. 5.4.4.1 GCC
    2. 5.4.4.2 South Africa
    3. 5.4.4.3 Rest of Middle East & Africa
  5. 5.4.5 South America
    1. 5.4.5.1 Brazil
    2. 5.4.5.2 Argentina
    3. 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Abbott Nutrition
  2. 6.1.2 Nestle Health Science
  3. 6.1.3 Baxter Healthcare
  4. 6.1.4 B. Braun Melsungen AG
  5. 6.1.5 Nutricia
  6. 6.1.6 BASF SE
  7. 6.1.7 Perrigo Company PLC
  8. 6.1.8 Fresenius Kabi
  9. 6.1.9 Danone

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments